Copeland Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Copeland Capital Management's LLY Position: Q3 2026 in Review
Copeland Capital Management increased its Eli Lilly (LLY) stake by 0.08% in Q3 2026, buying an estimated $15.3K and bringing the position to 16,895 shares worth $19.5M. The position accounts for 0.45% of the portfolio, ranked #89.
Copeland Capital Management first reported a position in LLY in Q4 2018 and has held it in 32 quarters since. The position peaked at $23.9M in Q2 2024. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Copeland Capital Management held 16,895 shares of Eli Lilly worth $19.5M as of Q3 2026.
- Copeland Capital Management bought 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
- Eli Lilly made up 0.45% of Copeland Capital Management's portfolio in Q3 2026, its #89 holding.
- Copeland Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 32 quarters since.
- Copeland Capital Management's Eli Lilly position peaked at $23.9M in Q2 2024.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Copeland Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.